How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics

Reproductive BioMedicine Online

Volumn 30, Issue 6, 2015, Pages 581-592

  Patrizio, Pasquale ^a   Vaiarelli, Alberto ^b   Levi Setti, Paolo E ^c   Tobler, Kyle J ^d   Shoham, Gon ^e   Leong, Milton ^f   Shoham, Zeev ^g,h  

^a YALE UNIVERSITY   (United States)

^b CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TEL AVIV UNIVERSITY   (Israel)

^f Women's Clinic   (Hong Kong)

^g KAPLAN MEDICAL CENTER   (Israel)

^h HEBREW UNIVERSITY   (Israel)

Author keywords

decreased ovarian function; IVF; management; ovarian stimulation; poor responder; survey

Indexed keywords

ACETYLSALICYLIC ACID; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN DERIVATIVE; GONADOTROPIN; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT LUTEINIZING HORMONE;

ARTICLE; CLINICAL PROTOCOL; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FERTILIZATION IN VITRO; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; OVARY FOLLICLE; TREATMENT RESPONSE; EVIDENCE BASED MEDICINE; FEMALE; INTERNATIONAL COOPERATION; INTERNET; MALE; PREGNANCY; PREGNANCY RATE; QUESTIONNAIRE;

EVIDENCE-BASED MEDICINE; FEMALE; FERTILIZATION IN VITRO; HUMANS; INTERNATIONALITY; INTERNET; MALE; PREGNANCY; PREGNANCY RATE; SURVEYS AND QUESTIONNAIRES;

EID: 84930924232     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2015.03.002     Document Type: Article

References (96)

1. L.F.J.M.M. Bancsi, F.J.M. Broekmans, C.W.N. Looman, J.D.F. Habbema, and E.R. te Velde Predicting poor ovarian response in IVF: use of repeat basal FSH measurement J. Reprod. Med 49 2004 187 194
2. K. Barnhart, R. Dunsmoor-Su, and C. Coutifaris Effect of endometriosis on in vitro fertilization Fertil. Steril 77 2002 1148 1155
3. N.G.M. Beckers, N.S. Macklon, M.J.C. Eijkemans, and B.C.J.M. Fauser Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging Fertil. Steril 78 2002 291 297
4. M. Berkkanoglu, M. Isikoglu, D. Aydin, and K. Ozgur Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders Fertil. Steril 88 2007 665 669
5. M.M. Biljan, W.M. Buckett, N. Dean, S.J. Phillips, and Tan S.L. The outcome of IVF-embryo transfer treatment in patients who develop three follicles or less Hum. Reprod 15 2000 2140 2144
6. J.K. Bosdou, C.A. Venetis, E.M. Kolibianakis, K.A. Toulis, D.G. Goulis, L. Zepiridis, and B.C. Tarlatzis The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis Hum. Reprod. Update 18 2012 127 145
7. F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk A systematic review of tests predicting ovarian reserve and IVF outcome Hum. Reprod. Update 12 2006 685 718
8. S.L. Broer, M. Dólleman, J. van Disseldorp, K.A. Broeze, B.C. Opmeer, P.M.M. Bossuyt, M.J.C. Eijkemans, B.W. Mol, F.J.M. Broekmans IPD-EXPORT Study Group Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis Fertil. Steril 100 2013 420 429
9. J.R. Brown, Liu H.C., K.F. Sewitch, Z. Rosenwaks, and A.S. Berkeley Variability of day 3 follicle-stimulating hormone levels in eumenorrheic women J. Reprod. Med 40 1995 620 624
10. R.G. Brzyski, S.J. Muasher, K. Droesch, S. Simonetti, G.S. Jones, and Z. Rosenwaks Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment Fertil. Steril 50 1988 917 921
11. I.T. Cameron, F.C. O'Shea, J.M. Rolland, E.G. Hughes, D.M. de Kretser, and D.L. Healy Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations J. Clin. Endocrinol. Metab 67 1988 1190 1194
12. Chong A.P., R.W. Rafael, and C.C. Forte Influence of weight in the induction of ovulation with human menopausal gonadotropin and human chorionic gonadotropin Fertil. Steril 46 1986 599 603
13. G. D'Amato, E. Caroppo, A. Pasquadibisceglie, D. Carone, A. Vitti, and G.M. Vizziello A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years Fertil. Steril 81 2004 1572 1577
14. H. Déchaud, G. Ferron, T. Anahory, F. Arnal, C. Humeau, and B. Hédon [Obesity and assisted reproduction techniques] Contracept. Fertil. Sex 26 1998 564 567
15. M. De Vos, P. Devroey, and B.C.J.M. Fauser Primary ovarian insufficiency Lancet 376 2010 911 921
16. A. El-Nemr, T. Al-Shawaf, L. Sabatini, C. Wilson, A.M. Lower, and J.G. Grudzinskas Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer Hum. Reprod 13 1998 2192 2198
17. M. Empson, M. Lassere, J. Craig, and J. Scott Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant Cochrane Database Syst. Rev 2 2005 10.1002/14651858 CD002859
18. B.M. Faber, J. Mayer, B. Cox, D. Jones, J.P. Toner, S. Oehninger, and S.J. Muasher Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders Fertil. Steril 69 1998 826 830
19. M.J. Faddy Follicle dynamics during ovarian ageing Mol. Cell. Endocrinol 163 2000 43 48
20. M.J. Faddy, R.G. Gosden, A. Gougeon, S.J. Richardson, and J.F. Nelson Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause Hum. Reprod 7 1992 1342 1346
21. R. Fanchin, D. de Ziegler, F. Olivennes, J. Taieb, A. Dzik, and R. Frydman Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting "poor responders" in in-vitro fertilization Hum. Reprod 9 1994 1607 1611
22. A.P. Ferraretti, L. Gianaroli, M.C. Magli, A. D'angelo, V. Farfalli, and N. Montanaro Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques Fertil. Steril 82 2004 1521 1526
23. A.P. Ferraretti, A. La Marca, B.C.J.M. Fauser, B. Tarlatzis, G. Nargund, L. Gianaroli ESHRE Working Group on Poor Ovarian Response Definition ESHRE consensus on the definition of "poor response" to ovarian stimulation for in vitro fertilization: the Bologna criteria Hum. Reprod 26 2011 1616 1624
24. M. Filicori, G.E. Cognigni, S. Taraborrelli, L. Parmegiani, S. Bernardi, and W. Ciampaglia Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis Fertil. Steril 78 2002 414 416
25. M. Filicori, G.E. Cognigni, E. Gamberini, L. Parmegiani, E. Troilo, and B. Roset Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation Fertil. Steril 84 2005 394 401
26. J.L. Frattarelli, G.D.E. McWilliams, M.J. Hill, K.A. Miller, and R.T. Scott Jr. Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders Fertil. Steril 89 2008 1113 1117
27. M. Fridström, E. Akerlöf, P. Sjöblom, and T. Hillensjö Serum levels of luteinizing and follicle-stimulating hormones in normal and poor-responding patients undergoing ovarian stimulation with urofollitropin after pituitary downregulation Gynecol. Endocrinol 11 1997 25 28
28. J. Galey-Fontaine, I. Cédrin-Durnerin, R. Chaïbi, N. Massin, and J.-N. Hugues Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders Reprod. Biomed. Online 10 2005 94 99
29. J.E. Garcia, G.S. Jones, A.A. Acosta, and G. Wright Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981 Fertil. Steril 39 1983 174 179
30. J.A. Garcia-Velasco, and E. Somigliana Management of endometriomas in women requiring IVF: to touch or not to touch Hum. Reprod 24 2009 496 501
31. T.A. Gelbaya, M. Kyrgiou, Li T.C., C. Stern, and L.G. Nardo Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis Hum. Reprod. Update 13 2007 357 364
32. N. Gleicher, A. Weghofer, and D.H. Barad A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies Fertil. Steril 91 2009 1707 1711
33. R.K. Goswamy, G. Williams, and P.C. Steptoe Decreased uterine perfusion-a cause of infertility Hum. Reprod 3 1988 955 959
34. A. Gougeon Regulation of ovarian follicular development in primates: facts and hypotheses Endocr. Rev 17 1996 121 155
35. J.E. Hall, C.K. Welt, and D.W. Cramer Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome Hum. Reprod 14 1999 409 415
36. J. Hanoch, Y. Lavy, H. Holzer, A. Hurwitz, A. Simon, A. Revel, and N. Laufer Young low responders protected from untoward effects of reduced ovarian response Fertil. Steril 69 1998 1001 1004
37. C.R. Harlow, S.G. Hillier, and J.K. Hodges Androgen modulation of follicle-stimulating hormone-induced granulosa cell steroidogenesis in the primate ovary Endocrinology 119 1986 1403 1405
38. D.J. Hendriks, E.R. te Velde, C.W.N. Looman, L.F.J.M.M. Bancsi, and F.J.M. Broekmans Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool Reprod. Biomed. Online 17 2008 727 736
39. M.J. Hill, E.D. Levens, G. Levy, M.E. Ryan, J.M. Csokmay, A.H. De Cherney, and B.W. Withcomb The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis Fertil. Steril 97 2012 1108 1114
40. S.G. Hillier, and F.A. De Zwart Evidence that granulosa cell aromatase induction/activation by follicle-stimulating hormone is an androgen receptor-regulated process in-vitro Endocrinology 109 1981 1303 1305
41. S.G. Hillier, M. Tetsuka, and H.M. Fraser Location and developmental regulation of androgen receptor in primate ovary Hum. Reprod 12 1997 107 111
42. B.S. Hurst, J.T. Bhojwani, P.B. Marshburn, M.A. Papadakis, T.A. Loeb, and M.L. Matthews Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization J. Exp. Clin. Assist. Reprod 2 2005 8 10.1186/1743-1050-2-8
43. V. Karande, and N. Gleicher A rational approach to the management of low responders in in-vitro fertilization Hum. Reprod 14 1999 1744 1748
44. E.R. Klinkert, F.J.M. Broekmans, C.W.N. Looman, and E.R. Te Velde A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles Fertil. Steril 81 2004 1247 1253
45. A. La Marca, G. Sighinolfi, S. Giulini, M. Traglia, C. Argento, C. Sala, C. Masciullo, A. Volpe, and D. Toniolo Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles Reprod. Biomed. Online 21 2010 463 469
46. A. La Marca, E. Spada, G. Sighinolfi, C. Argento, A. Tirelli, S. Giulini, S. Milani, and A. Volpe Age-specific nomogram for the decline in antral follicle count throughout the reproductive period Fertil. Steril 95 2011 684 688
47. J.A. Land, M.I. Yarmolinskaya, J.C. Dumoulin, and J.L. Evers High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome Fertil. Steril 65 1996 961 965
48. A. Lass, J. Skull, E. McVeigh, R. Margara, and R.M. Winston Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response Hum. Reprod 12 1997 294 297
49. F.L. Licciardi, Liu H.C., and Z. Rosenwaks Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization Fertil. Steril 64 1995 991 994
50. I.H. Lok, S.-K. Yip, L.P. Cheung, P.H. Yin Leung, and C.J. Haines Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial Fertil. Steril 81 2004 556 561
51. D.L. Manzi, K.L. Thornton, L.B. Scott, and J.C. Nulsen The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response Fertil. Steril 62 1994 251 256
52. F. Morgia, M. Sbracia, M. Schimberni, A. Giallonardo, C. Piscitelli, P. Giannini, and C. Aragona A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization Fertil. Steril 81 2004 1542 1547
53. S.J. Muasher, S. Oehninger, S. Simonetti, J. Matta, L.M. Ellis, Liu H.C., G.S. Jones, and Z. Rosenwaks The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome Fertil. Steril 50 1988 298 307
54. L.G. Nardo, I. Granne, J. Stewart Policy & Practice Committee of the British Fertility Society Medical adjuncts in IVF: evidence for clinical practice Hum. Fertil. (Camb.) 12 2009 1 13
55. G. Nargund, Cheng W.C., and J. Parsons The impact of ovarian cystectomy on ovarian response to stimulation during in-vitro fertilization cycles Hum. Reprod 11 1996 81 83
56. D. Navot, Z. Rosenwaks, and E.J. Margalioth Prognostic assessment of female fecundity Lancet 2 1987 645 647
57. D. Nikolaou, and A. Templeton Early ovarian ageing: a hypothesis. Detection and clinical relevance Hum. Reprod 18 2003 1137 1139
58. O. Oktem, and K. Oktay Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function Cancer 110 2007 2222 2229
59. R. Orvieto, S. Meltcer, R. Nahum, J. Rabinson, E.Y. Anteby, and J. Ashkenazi The influence of body mass index on in vitro fertilization outcome Int. J. Gynaecol. Obstet 104 2009 53 55
60. J.F. Oudendijk, F. Yarde, M.J. Eijkemans, F.J. Broekmans, and S.L. Broer The poor responder in IVF: is the prognosis always poor? A systematic review Hum. Reprod. Update 18 2012 1 11
61. Z. Pandian, A.R. McTavish, L. Aucott, M.P. Hamilton, and S. Bhattacharya Interventions for "poor responders" to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF) Cochrane Database Syst. Rev 1 2010 10.1002/14651858.CD004379.pub3 CD004379
62. C. Patrono, L.A. García Rodríguez, R. Landolfi, and C. Baigent Low-dose aspirin for the prevention of atherothrombosis N. Engl. J. Med 353 2005 2373 2383
63. M. Päkkilä, J. Räsänen, S. Heinonen, H. Tinkanen, L. Tuomivaara, K. Mäkikallio, M. Hippeläinen, J.S. Tapanainen, and H. Martikainen Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study Hum. Reprod 20 2005 2211 2214
64. A.S. Penzias Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction Reprod. Biomed. Online 9 2004 43 46
65. Practice Committee of American Society for Reproductive Medicine Anti-phospholipid antibodies do not affect IVF success Fertil. Steril 90 2008 S172 S173
66. Pu D., Wu J., and Liu J. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF Hum. Reprod 26 2011 2742 2749
67. F. Raga, F. Bonilla-Musoles, E.M. Casañ, and F. Bonilla Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome Hum. Reprod 14 1999 1431 1434
68. L. Rombauts, A.M. Suikkari, V. MacLachlan, A.O. Trounson, and D.L. Healy Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle Fertil. Steril 69 1998 665 669
69. M. Rubinstein, A. Marazzi, and E. Polak de Fried Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay Fertil. Steril 71 1999 825 829
70. H.N. Sallam, F. Ezzeldin, A.F. Agameya, A.F. Rahman, and Y. El-Garem Defining poor responders in assisted reproduction Int. J. Fertil. Womens Med 50 2005 115 120
71. H.N. Sallam, F. Ezzeldin, A.F. Agameya, A.F. Abdel-Rahman, and Y. El-Garem The definition of poor response: the Bologna criteria Hum. Reprod 27 2012 626 627
72. M. Schimberni, F. Morgia, J. Colabianchi, A. Giallonardo, C. Piscitelli, P. Giannini, M. Montigiani, and M. Sbracia Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles Fertil. Steril 92 2009 1297 1301
73. W. Schoolcraft, T. Schlenker, M. Gee, J. Stevens, and L. Wagley Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol Fertil. Steril 67 1997 93 97
74. A.G. Shaker, R. Fleming, M.E. Jamieson, R.W. Yates, and J.R. Coutts Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders Fertil. Steril 58 1992 919 923
75. D.B. Smotrich, E.A. Widra, P.R. Gindoff, M.J. Levy, J.L. Hall, and R.J. Stillman Prognostic value of day 3 estradiol on in vitro fertilization outcome Fertil. Steril 64 1995 1136 1140
76. C.V. Steer, S. Campbell, Tan S.L., T. Crayford, C. Mills, B.A. Mason, and W.P. Collins The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer Fertil. Steril 57 1992 372 376
77. E.S. Surrey, and W.B. Schoolcraft Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques Fertil. Steril 73 2000 667 676
78. E.S. Surrey, J. Bower, D.M. Hill, J. Ramsey, and M.W. Surrey Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization Fertil. Steril 69 1998 419 424
79. E.R. te Velde, and P.L. Pearson The variability of female reproductive ageing Hum. Reprod. Update 8 2002 141 154
80. C. Tomas, S. Nuojua-Huttunen, and H. Martikainen Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization Hum. Reprod 12 1997 220 223
81. J.P. Toner, C.B. Philput, G.S. Jones, and S.J. Muasher Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age Fertil. Steril 55 1991 784 791
82. T.L. Toth, J.T. Awwad, L.L. Veeck, H.W. Jones Jr., and S.J. Muasher Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program J. Reprod. Med 41 1996 321 326
83. A.E. Treloar Menstrual cyclicity and the pre-menopause Maturitas 3 1981 249 264
84. F.M. Ubaldi, L. Rienzi, S. Ferrero, E. Baroni, F. Sapienza, L. Cobellis, and E. Greco Management of poor responders in IVF Reprod. Biomed. Online 10 2005 235 246
85. B. Urman, K. Yakin, and B. Balaban Recurrent implantation failure in assisted reproduction: how to counsel and manage. A. General considerations and treatment options that may benefit the couple Reprod. Biomed. Online 11 2005 371 381
86. M.H. van Hooff, A.T. Alberda, G.J. Huisman, G.H. Zeilmaker, and R.A. Leerentveld Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study Hum. Reprod 8 1993 369 373
87. P.A. van Noord, J.S. Dubas, M. Dorland, H. Boersma, and E. te Velde Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors Fertil. Steril 68 1997 95 102
88. E. Vaisbuch, M. Leong, and Z. Shoham Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey Reprod. Biomed. Online 25 2012 139 145
89. Z. Veleva, I.Y. Järvelä, S. Nuojua-Huttunen, H. Martikainen, and J.S. Tapanainen An initial low response predicts poor outcome in in vitro fertilization/intracytoplasmic sperm injection despite improved ovarian response in consecutive cycles Fertil. Steril 83 2005 1384 1390
90. K.A. Vendola, Zhou J., O.O. Adesanya, S.J. Weil, and C.A. Bondy Androgens stimulate early stages of follicular growth in the primate ovary J. Clin. Invest 101 1998 2622 2629
91. T.E.M. Verhagen, D.J. Hendriks, L.F.J.M.M. Bancsi, B.W.J. Mol, and F.J.M. Broekmans The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis Hum. Reprod. Update 14 2008 95 100
92. U. Waldenström, D. Hellberg, and S. Nilsson Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study Fertil. Steril 81 2004 1560 1564
93. S.J. Weil, K. Vendola, Zhou J., O.O. Adesanya, Wang J., J. Okafor, and C.A. Bondy Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations J. Clin. Endocrinol. Metab 83 1998 2479 2485
94. S. Weil, K. Vendola, Zhou J., and C.A. Bondy Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development J. Clin. Endocrinol. Metab 84 1999 2951 2956
95. N. Wyndham, P.G. Marin Figueira, and P. Patrizio A persistent misperception: assisted reproductive technology can reverse the "aged biological clock" Fertil. Steril 97 2012 1044 1047
96. M.C. Yih, S.D. Spandorfer, and Z. Rosenwaks Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Fertil. Steril 83 2005 24 29